Novo Nordisk Bet Everything on a Pill Beating Lilly's Shot (thebusinessindex.co)
Novo Nordisk finally built a pill to answer Eli Lilly's injectable dominance. This week's earnings were supposed to prove the comeback was real. Instead, investors got a pointed reminder of exactly wh...
Novo Nordisk raised guidance this week. Its stock fell anyway 📉 Oral Wegovy missed sales targets, CagriSema still couldn't beat Eli Lilly's shot. Same day, Lilly posted a blowout quarter and soared 🚀 Read more via link below
